BEIJING, Jan. 22 (Xinhua) – Starmap Medicine & Technology Co., Ltd. (Starmap, 300143.SZ), a medical devices and services provider in South China's Guangdong Province, announced on Monday that it intends to sell 159-million A-shares to a medical investment company in Qingdao of east China's Shandong Province at a price of 11.5 yuan per share.
After the transaction is finished, the investment company will hold 29 percent of Starmap's stake, becoming its controlling shareholder.
It is reported that the investment company is a wholly-owned subsidiary of a technology company in southwest China's Chongqing controlled by Haier Group, meaning Haier will become Starmap's actual controller if the transaction is completed. (Edited by Gu Shanshan)
A single purchase
